| Supplementary Protection Certificate (SPC) Summary | |||
| SPC No. | 2008/018 | ||
|---|---|---|---|
| Date of filing | 16/05/2008 | ||
| Notification of Application Published | 25/06/2008 | ||
| Status | Surrendered | ||
| Notification of Grant Published | 02/09/2009 | ||
| Date of Expiry of SPC | 24/07/2022 | ||
| Applicant |
GILEAD SCIENCES, INC. 333 Lakeside Drive Foster City California 94404 UNITED STATES OF AMERICA |
||
| Patent Number | 0915894 | ||
| Title of Invention | NUCLEOTIDE ANALOGS | ||
| Date of Expiry of Patent | 24/07/2017 | ||
| Product Type | Medicinal Product | ||
| Product Identity | Tenofovir Disoproxil and the salts, in particular the Fumerate, hydrates, tautomers and solvates thereof in combination with Emtricitabine and Efavirenz. | Market Authorisation | Ireland | European Union |
| Authorisation No | EU/1/07/430/001 | EU/1/07/430/001 | |
| Authorisation Date | 13/12/2007 | 13/12/2007 | |
| Identity of Product Authorised | Atripla - efavirenz/emtricitabine/tenofovir disoproxil fumerate. | Atripla - efavirenz/emtricitabine/tenofovir disoproxil fumerate | |
| Address for Service |
TOMKINS & CO. 5 Dartmouth Road Dublin 6 IRELAND |
||
| Renewal Fees | |||
| 23/11/2015 | Application for surrender of a Supplementary Protection Certificate filed on 11/11/2015 is published in Journal No. 2296 dated 16/12/2015. | ||
| 07/04/2016 | Supplementary Protection Certificate surrendered on 07/04/2016. | ||